Early Vedolizumab as First-Line for Immune-Related Colitis Therapy Trial

Name: Early Vedolizumab as First-Line for Immune-Related Colitis Therapy Trial
License: Public Domain

Shilpa Grover, MD, MPH

ClinicalTrials.gov · Datasets · License: Public Domain

immune checkpoint inhibitor-related colitis

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 460102
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.